CIK 0000310158 · Large accelerated filer
Merck & Co., Inc.
Sign in to watch- Ticker
- MRK
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 221918501
- Phone
- 908-740-4000
- Business address
- 126 EAST LINCOLN AVENUE, P.O. BOX 2000, RAHWAY, NJ, 07065
- Former names
- Merck & Co. Inc., SCHERING PLOUGH CORP
- 144 Insider Sale of Securities
- 4 Open-market sale President, U.S. Market sold 18,959 shares at $127.18 ($2,411,111)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale EVP, Chief HR Officer sold 50,694 shares at $126.65 ($6,420,349)
- 4 Open-market sale EVP, General Counsel sold 49,499 shares at $126.97 ($6,284,779)
- 8-K Event Results of operations · Exit or restructuring costs
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award President, U.S. Market acquired 3,133 shares (grant or award)
- 4 Grant or award SVP Fin. - Global Controller acquired 2,661 shares (grant or award)
- 4 Grant or award EVP,Chief Info&Digital Officer acquired 10,196 shares (grant or award)
- 4 Grant or award EVP, Chief HR Officer acquired 18,384 shares (grant or award)
- 4 Grant or award EVP, General Counsel acquired 23,298 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 18 of 152 · 3,038 filings